Brilinta posts

Feed

Good news for a new AstraZeneca drug

There is good news surfacing for pharmaceutical firm AstraZeneca (NYSE: AZN) this morning. Turns out a new drug produced by AZN helps reduce heart patients' chances of dying by more than 20% when compared to the standard treatment. The drug is designed to prevent blood clots in heart patients.

The study followed 18,624 patients from 2006 to 2008, with roughly half taking rival medicine Plavix and the other half taking AZN's Brilinta. The results show that patients taking Brilinta had a 4.5% chance of dying, compared to a 5.9% chance for patients on Plavix.

Continue reading Good news for a new AstraZeneca drug

Symbol Lookup
IndexesChangePrice
DJIA+72.8112,874.04
NASDAQ+27.512,931.39
S&P 500+9.131,351.77

Last updated: February 13, 2012: 06:26 PM

Hot Stocks

General Electric

19.07+0.195(+1.03)

Alcoa

10.33+0.04(+0.39)

Apple Inc

502.60+9.18(+1.86)

Google Inc 'A'

612.20+6.29(+1.04)

Bank of America

8.25+0.18(+2.23)

Wal-Mart Stores

61.79-0.11(-0.18)

Exxon Mobil Corp

84.42+0.62(+0.74)

Ford

12.54+0.10(+0.80)

Citigroup

32.88-0.045(-0.14)

IBM

192.62+0.20(+0.10)

Yahoo

16.12-0.02(-0.12)

Starbucks

49.25+0.43(+0.88)

Microsoft

30.58+0.085(+0.28)

Home Depot

45.93+0.60(+1.32)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1329175569985 ms.